Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.135 | 0.9824 | 0.9706 |
Mycobacterium ulcerans | hypothetical protein | 0.081 | 0.5734 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.135 | 0.9824 | 0.9706 |
Giardia lamblia | Hypothetical protein | 0.081 | 0.5734 | 0.5 |
Entamoeba histolytica | phosphoglycerate mutase family protein, putative | 0.081 | 0.5734 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.135 | 0.9824 | 0.9824 |
Loa Loa (eye worm) | hypothetical protein | 0.0787 | 0.5558 | 0.5558 |
Giardia lamblia | Hypothetical protein | 0.081 | 0.5734 | 0.5 |
Trypanosoma brucei | 6-phosphofructo-2-kinase 2 | 0.135 | 0.9824 | 0.9706 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.025 | 0.1482 | 0.5 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.135 | 0.9824 | 0.9706 |
Mycobacterium ulcerans | fructose-2,6-bisphosphatase GpmB | 0.081 | 0.5734 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.